Monoamine oxidase-B inhibitors in the treatment of Parkinson’s disease: clinical–pharmacological aspects (English)
- New search for: Riederer, Peter
- New search for: Müller, Thomas
- New search for: Riederer, Peter
- New search for: Müller, Thomas
In:
Journal of Neural Transmission
;
125
, 11
; 1751-1757
;
2018
-
ISSN:
- Article (Journal) / Electronic Resource
-
Title:Monoamine oxidase-B inhibitors in the treatment of Parkinson’s disease: clinical–pharmacological aspects
-
Contributors:Riederer, Peter ( author ) / Müller, Thomas ( author )
-
Published in:Journal of Neural Transmission ; 125, 11 ; 1751-1757
-
Publisher:
- New search for: Springer Vienna
- New search for: Springer
-
Place of publication:Wien [u.a.]
-
Publication date:2018
-
ISSN:
-
ZDBID:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
- New search for: 44.90
- Further information on Basic classification
-
Keywords:
-
Classification:
BKL: 44.90 Neurologie -
Source:
Table of contents – Volume 125, Issue 11
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1517
-
Introduction to the special issue on monoamine oxidase A and B: eternally enigmatic isoenzymesShih, Jean Chen / Riederer, Peter / Maruyama, Wakako / Naoi, Makoto et al. | 2018
- 1519
-
90 years of monoamine oxidase: some progress and some confusionTipton, Keith F. et al. | 2018
- 1553
-
Monoamine oxidase isoenzymes: genes, functions and targets for behavior and cancer therapyShih, Jean C. et al. | 2018
- 1567
-
The structure of monoamine oxidases: past, present, and futureIacovino, Luca Giacinto / Magnani, Francesca / Binda, Claudia et al. | 2018
- 1581
-
Epigenetic signature of MAOA and MAOB genes in mental disordersZiegler, Christiane / Domschke, Katharina et al. | 2018
- 1589
-
From aggression to autism: new perspectives on the behavioral sequelae of monoamine oxidase deficiencyBortolato, Marco / Floris, Gabriele / Shih, Jean C. et al. | 2018
- 1601
-
Gene–environment interaction of monoamine oxidase A in relation to antisocial behaviour: current and future directionsNilsson, Kent W. / Åslund, Cecilia / Comasco, Erika / Oreland, Lars et al. | 2018
- 1627
-
Monoamine oxidase-A, serotonin and norepinephrine: synergistic players in cardiac physiology and pathologyMialet-Perez, Jeanne / Santin, Yohan / Parini, Angelo et al. | 2018
- 1635
-
Type A and B monoamine oxidases distinctly modulate signal transduction pathway and gene expression to regulate brain function and survival of neuronsNaoi, Makoto / Maruyama, Wakako / Shamoto-Nagai, Masayo et al. | 2017
- 1651
-
An inducible MAO-B mouse model of Parkinson’s disease: a tool towards better understanding basic disease mechanisms and developing novel therapeuticsChamoli, Manish / Chinta, Shankar J. / Andersen, Julie K. et al. | 2018
- 1659
-
Kinetics, mechanism, and inhibition of monoamine oxidaseRamsay, Rona R. / Albreht, Alen et al. | 2018
- 1685
-
On the practical aspects of characterising monoamine oxidase inhibition in vitroHolt, Andrew et al. | 2018
- 1707
-
A reassessment of the safety profile of monoamine oxidase inhibitors: elucidating tired old tyramine mythsGillman, Peter Kenneth et al. | 2018
- 1719
-
Monoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseasesYoudim, Moussa B. H. et al. | 2018
- 1735
-
Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson’s diseaseSzökő, Éva / Tábi, Tamás / Riederer, Peter / Vécsei, László / Magyar, Kálmán et al. | 2018
- 1751
-
Monoamine oxidase-B inhibitors in the treatment of Parkinson’s disease: clinical–pharmacological aspectsRiederer, Peter / Müller, Thomas et al. | 2018